Business

MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board

MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board.

articleInstitute Of Biomedical Research Corp.July 19, 20234/company/institute-of-biomedical-research-corp/news/mres-m2bio-sciences-appoints-adrian-j-maizey-accomplished-ceo-and-financial-expert-to-advisory-board
MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board

About this update from Institute Of Biomedical Research Corp.

[{"type":"text","content":"\n CAPE TOWN, South Africa, July 19, 2023 (GLOBE NEWSWIRE) -- via IBN -- Institute of Biomedical Research Corp. (OTC PINK: MRES) (\"Institute of Biomedical Research\" or the \"Company\"), a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions, is pleased to share the following update: M2Bio Sciences, a trailblazing biotechnology company committed to pioneering groundbreaking research, is proud to announce the appointment of Adrian Maizey to its esteemed Advisory Board. A distinguished leader and financial and data analytics expert, Adrian Maizey brings a wealth of experience and expertise from his prior roles in top-tier firms with a focus spanning New York Stock Exchange and Johannesburg Stock Exchange companies, the US private equity and hedge fund industries, and South African private consumer retail companies. Adrian Maizey is the Chief Executive Officer of Rand Capital Coffee, the exclusive licensee for Starbucks in Southern Africa. Founded in 2019, Rand Capital Coffee owns and operates 65 Starbucks cafes across Southern Africa, a testament to Adrian's remarkable leadership in the region's food and beverage industry. Rand Capital Coffee is a subsidiary of Rand Capital, an investment advisory firm Adrian founded in 2012. Prior to his role at Rand Capital, Adrian held several key positions in prestigious financial and investment firms, showcasing his versatile capabilities. Notably, Adrian served as the Chief Financial and Chief Compliance Officer of ESL Investments, Inc., a group of long-term concentrated value investment funds founded by legendary investor Edward S. Lampert. During his tenure, ESL managed $22 billion and held core investments in companies such as Sears Holdings, AutoNation, and AutoZone. Adrian oversaw the company's operations, including legal, tax, accounting, treasury, finance, investor relations, research, marketing, and compliance departments. Adrian's vast experience also includes serving as the Chief Operating Officer and Chief Compliance Officer of Leonard Green & Partners, L.P., a leading Los Angeles-based private equity firm with $70 billion under management. Adrian managed the firm's operations, including its le...

More updates from Institute Of Biomedical Research Corp.